Clinical trials of tirzepatide show heartburn and reflux reported in 812% of participants, most commonly in weeks 14 as the body adapts to slower gastric emptying
Clinical trials show a measurable increase in gallbladder events among tirzepatide users
In particular, levels of L-arginine, L-proline, and L-glutamic acid were elevated, whereas glutathione, L-tyrosine, and L-phenylalanyl-L-proline levels were reduced
At 10 mg/mL in a 3.0 mL fill, the same pen supports anything from 30 1 mg draws to 2 15 mg draws without opening a second unit, which simplifies batch-tying when results are later mapped back to a single certificate of analysis
In some individuals, this slowing effect extends to the large bowel, contributing to constipation